Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Galera Therapeutics, Inc. (GRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 22,762 options to buy
@ $3.12, valued at
$71k
|
|
| 07/05/2023 |
4
| West Linda (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 23,382 options to buy
@ $3.12, valued at
$73k
|
|
| 06/16/2023 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 64,000 options to buy
@ $3.27, valued at
$209.3k
|
|
| 06/16/2023 |
4
| West Linda (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 48,000 options to buy
@ $3.27, valued at
$157k
|
|
| 06/16/2023 |
4
| LOKAY KEVIN G (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 48,000 options to buy
@ $3.27, valued at
$157k
|
|
| 06/16/2023 |
4
| Cunningham Emmett (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 48,000 options to buy
@ $3.27, valued at
$157k
|
|
| 06/16/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 48,000 options to buy
@ $3.27, valued at
$157k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Bought 100,000 shares
@ $1.6812, valued at
$168.1k
|
|
| 03/14/2023 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.9593, valued at
$19.6k
|
|
| 02/28/2023 |
4
| Beardsley Robert A (COO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.78, valued at
$240.3k
|
|
| 02/28/2023 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 440,000 options to buy
@ $1.78, valued at
$783.2k
|
|
| 02/28/2023 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 185,000 options to buy
@ $1.78, valued at
$329.3k
|
|
| 02/28/2023 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $1.78, valued at
$97.9k
|
|
| 02/28/2023 |
4
| Bachleda Mark (Chief Commercial Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.78, valued at
$240.3k
|
|
| 02/28/2023 |
4
| Stacey Jennifer Evans (See Remarks) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.78, valued at
$240.3k
|
|
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| Beardsley Robert A (COO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options
@ $1.07, valued at
$10.7k
|
|
| 09/02/2022 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.29, valued at
$193.5k
|
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| West Linda (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 58,496 options to buy
@ $1.29, valued at
$75.5k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| West Linda (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.48, valued at
$22.2k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Cunningham Emmett (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.48, valued at
$22.2k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $2.24, valued at
$302.4k
|
|
| 03/02/2022 |
4
| HOLMLUND JON T (Chief Medical Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.24, valued at
$168k
|
|
| 03/02/2022 |
4
| Bachleda Mark (Chief Commercial Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.24, valued at
$168k
|
|
| 03/02/2022 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 264,400 options to buy
@ $2.24, valued at
$592.3k
|
|
| 12/20/2021 |
4
| West Linda (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $2.7402, valued at
$54.8k
|
|
| 12/20/2021 |
4
| Beardsley Robert A (COO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Exercised 20,000 options
@ $1.07, valued at
$21.4k
|
|
|
|
|